The primary target cell for α-MSH is the melanocyte, in which, despite the proven efficacy in the prevention of melanoma development, its role in malignant melanoma, and in particular in metastatic stage disease still remains underinvestigated [6]. This evidence concerns the gene STAMBP and melanoma.